BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sato W, Ono H, Matsutani T, Nakamura M, Shin I, Amano K, Suzuki R, Yamamura T. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun 2021;95:245-55. [PMID: 33794313 DOI: 10.1016/j.bbi.2021.03.023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Vogl T, Kalka IN, Klompus S, Leviatan S, Weinberger A, Segal E. Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients. Sci Adv 2022;8:eabq2422. [PMID: 36149952 DOI: 10.1126/sciadv.abq2422] [Reference Citation Analysis]
2 Renz-polster H, Tremblay M, Bienzle D, Fischer JE. The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure. Front Cell Neurosci 2022;16:888232. [DOI: 10.3389/fncel.2022.888232] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brownlie H, Speight N. Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare (Basel) 2021;9:1546. [PMID: 34828592 DOI: 10.3390/healthcare9111546] [Reference Citation Analysis]
4 Fluge Ø, Tronstad KJ, Mella O. Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Clin Invest 2021;131:150377. [PMID: 34263741 DOI: 10.1172/JCI150377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]